The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry



Status:Recruiting
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 100
Updated:2/20/2019
Start Date:January 2009
End Date:January 2024
Contact:Phillip M Pierorazio, MD
Email:philpierorazio@jhmi.edu
Phone:410 502 5984

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Retrospective studies indicate that active surveillance for clinically localized, small renal
masses (cT1a, <=4cm) is safe. It is our hypothesis that active surveillance is safe and
efficacious when compared prospectively to patients undergoing immediate intervention for
their small renal mass.

All patients are offered active surveillance or immediate intervention, as applicable, prior
to being offered consent for the DISSRM Registry. All patients are enrolled and followed
prospectively. Surveillance patients are followed per protocol with serial imaging, blood
work and quality of life questionnaires. Intervention patients are followed at the discretion
of the attending surgeon with serial QOL appointments/questionnaires.

Inclusion Criteria:

- Must have a solid, enhancing renal mass ≤4cm at its greatest dimension found on
incidental scanning in the last 6 months.

- Age ≥ 18 and able to read, understand and sign informed consent.

- Must be willing to adhere to the treatment algorithm and time constraints therein.

Exclusion Criteria:

- Cannot have suspicion of metastases to the kidney if any other malignancy diagnosed
within two years of study entry.
We found this trial at
1
site
Johns Hopkins Hospital
1800 Orleans St.
Baltimore, Maryland 21287
410-955-5000
Phone: 410-502-5984
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials